Sector
PharmaceuticalsOpen
₹1,083Prev. Close
₹1,086.4Turnover(Lac.)
₹6,273.77Day's High
₹1,108.8Day's Low
₹1,05952 Week's High
₹1,32252 Week's Low
₹607.5Book Value
₹162.92Face Value
₹5Mkt Cap (₹ Cr.)
9,052.25P/E
56.66EPS
19.49Divi. Yield
0.14Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 36.88 | 36.44 | 36.44 | 31.5 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 638.23 | 550.35 | 481.57 | 132.45 |
Net Worth | 675.11 | 586.79 | 518.01 | 163.95 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 |
---|---|---|
Revenue | 520.13 | 340.6 |
yoy growth (%) | 52.7 | |
Raw materials | -272.83 | -179.68 |
As % of sales | 52.45 | 52.75 |
Employee costs | -41.36 | -20.98 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 |
---|---|---|
Profit before tax | 91.45 | 71.72 |
Depreciation | -10.08 | -4.18 |
Tax paid | -19.5 | -17.72 |
Working capital | 186.55 | |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 |
---|---|---|
Growth matrix (%) | ||
Revenue growth | 52.7 | |
Op profit growth | 31.13 | |
EBIT growth | 26.52 | |
Net profit growth | 33.23 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 1,006.88 | 717.47 | 616.73 | 520.14 | 340.61 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,006.88 | 717.47 | 616.73 | 520.14 | 340.61 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 16.93 | 7.49 | 4.32 | 2.76 | 1.38 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.6 | 93.59 | 4,00,808.91 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,586.5 | 79.14 | 1,74,808.41 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,510 | 25.34 | 1,21,963.88 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,341.6 | 20.92 | 1,11,903.46 | 1,200.7 | 0.6 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,226.7 | 57.3 | 1,09,169.13 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Nareshbhai Ramjibhai Patel
Whole-time Director
Chetankumar Chhaganlal Vaghasia
Whole-time Director
Virendra Nath Mishra
Whole-time Director
Ram Mohan Rao Locande
Independent Non Exe. Director
Girikrishna Maniar
Independent Non Exe. Director
Hetal Gandhi
Independent Non Exe. Director
Richa M. Goyal
Independent Non Exe. Director
Anita Bandyopadhyay
Company Sec. & Compli. Officer
Ekta Kumari Srivastava
Plot No 440/4 5&6,
Road No 82/A GIDC Sachin,
Gujarat - 394230
Tel: 91-261-2397193/91-7227977744
Website: http://www.amiorganics.com
Email: cs@amiorganics.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Ami Organics Limited was initially formed as a partnership firm in the name of Ami Organics with effect from 03 January, 2004 at Surat, India. The Firm converted into a Private Limited Company under t...
Read More
Reports by Ami Organics Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.